from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. An oxazolidinone drug being developed to treat skin infections.


Sorry, no etymologies found.


  • In December 2010, research was published elucidating the mechanism by which an investigational second generation oxazolidinone called torezolid phosphate retains full activity against clinical isolates of Staphylococcus aureus carrying the cfr gene.

  • TSRX - News) announced today that the Company has completed the enrollment of the first of two planned Phase 3 trials of tedizolid phosphate (formerly known as torezolid phosphate) in the study of acute bacterial skin and skin structure infections (ABSSSI).

  • Ms. Bayko says the stock was hurt because Trius wasn't going to be able to provide any Phase III clinical-trial data on its antibiotic, torezolid, until the beginning of 2012.


  • Trius Therapeutics TSRX said today it had come to an agreement with the US Food and Drug Administration on the design of a second phase 3 study for torezolid phosphate.

    Trius Therapeutics Reaches Deal For New Study

  • Based in San Diego, Trius Therapeutics is a biopharmaceutical company focused on the developing its first drug, torezolid phosphate, for the treatment of serious infections that include methicillin-resistant Staphylococcus aureus, or MRSA.

    Trius Closes Flat After Cutting IPO Price

  • The company's lead investigational drug, torezolid phosphate, is an IV and orally administered second generation oxazolidinone in Phase 3 clinical development for the treatment of ABSSSI, the first such trial to be initiated under a Special Protocol Assessment SPA.

  • The potent activity of torezolid against cfr-positive bacteria differentiates it from linezolid, marketed by Pfizer as ZyvoxR, which is ineffective against cfr-positive strains.

  • In addition to the company's torezolid phosphate clinical program, it is currently conducting three preclinical programs using its proprietary discovery platform to develop antibiotics to treat infections caused by gram-negative bacteria.

  • "I look forward to joining this exciting company, leading the commercialization of torezolid phosphate into a successful anti-infective drug and creating value for our customers and shareholders."

    Trius Hires Chief Commercial Officer - Yahoo! Finance

  • "Trius provides a unique opportunity to launch torezolid phosphate, a best-in-class oxazolidinone, and to contribute to the development of its preclinical portfolio," stated

    Trius Hires Chief Commercial Officer - Yahoo! Finance


Log in or sign up to get involved in the conversation. It's quick and easy.